C-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

被引:0
|
作者
MacEwen, EG
Kutzke, J
Carew, J
Pastor, J
Schmidt, JA
Tsan, R
Thamm, DH
Radinsky, R
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA
[2] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
c-Met; canine; human; osteosarcoma; hepatocyte growth factor; invasion; molecular determinants; scatter factor; urokinase plasminogen activator;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To further characterize the role of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor (c-Met) in osteosarcoma (OS), human OS cell lines with low (SAOS-2) and high (SAOS-LM2) metastatic potential, and cell lines derived from spontaneous canine OS were studied. All cell lines were evaluated for c-Met and HGF-SF expression and receptor activation using Northern, RT-PCR, and Western blot analyses, respectively. Functional activity of receptor-ligand interaction was measured using c-Met phosphorylation status, proliferation assays (anchorage-dependent and - independent), Matrigel invasion, modulation of urokinase plasminogen activator (uPA) expression, and cell dispersion ( scattering). All cell lines exhibited steady-state mRNA expression of c-Met. The canine OS cell lines also expressed HGF-SF mRNA as determined by RT-PCR analysis. Western analysis showed c-Met protein expression and HGF-stimulated ( human) or constitutive ( canine) receptor autophosphorylation. Treatment with recombinant human HGF resulted in enhanced proliferation in 3 of 5 OS cell lines and enhanced colony formation in 2 of 5 OS cell lines. Matrigel invasion was significantly enhanced in 3 of the cell lines and uPA levels were significantly increased in the SAOS-2 cells following HGF treatment. Scattering was enhanced in both the SAOS-2 and SAOS-LM2 cells. These data support the involvement of c-Met and HGF-SF in the growth and progression of human and canine OS, and may offer new targets for the development of therapeutic strategies for OS.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 50 条
  • [31] Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and map kinase activity in pancreatic cancer cells
    Qian, LW
    Mizumoto, K
    Inadome, N
    Nagai, E
    Sato, N
    Matsumoto, K
    Nakamura, T
    Tanaka, M
    INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (05) : 542 - 549
  • [32] Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
    Dai, Yao
    Siemann, Dietmar W.
    BMC CANCER, 2012, 12
  • [33] Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells
    Parr, C
    Jiang, WG
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (04) : 857 - 863
  • [34] Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
    Lucia Demkova
    Lucia Kucerova
    Molecular Cancer, 17
  • [35] Sprouty-2 controls c-Met expression and metastatic potential of colon cancer cells: sprouty/c-Met upregulation in human colonic adenocarcinomas
    Holgren, C.
    Dougherty, U.
    Edwin, F.
    Cerasi, D.
    Taylor, I.
    Fichera, A.
    Joseph, L.
    Bissonnette, M.
    Khare, S.
    ONCOGENE, 2010, 29 (38) : 5241 - 5253
  • [36] Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells
    Mei, Liangwei
    Sang, Wenhua
    Cui, Kai
    Zhang, Yabin
    Chen, Fuchun
    Li, Xiaochun
    CANCER SCIENCE, 2019, 110 (02): : 582 - 595
  • [37] Vascular Niche Facilitates Acquired Drug Resistance to c-Met Inhibitor in Originally Sensitive Osteosarcoma Cells
    Tang, Weifeng
    Zhang, Yu
    Zhang, Haixia
    Zhang, Yan
    CANCERS, 2022, 14 (24)
  • [38] Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
    Demkova, Lucia
    Kucerova, Lucia
    MOLECULAR CANCER, 2018, 17
  • [39] KRC-327, a selective novel inhibitor of c-Met receptor tyrosine kinase with anticancer activity
    Park, Byung Hee
    Jung, Kyung Hee
    Yun, Sun-Mi
    Hong, Sang-Won
    Ryu, Jae Wook
    Jung, Heejung
    Ha, Jae Du
    Lee, Jongkook
    Hong, Soon-Sun
    CANCER LETTERS, 2013, 331 (02) : 158 - 166
  • [40] Expression of c-Met in laryngeal carcinoma
    Sawatsubashi, M
    Sasatomi, E
    Mizokami, H
    Tokunaga, O
    Shin, T
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1998, 432 (04): : 331 - 335